Go to Header
Go to Navigation
Go to Content
Go to Footer
Login
Help
中文(繁體)
Research Resources
CUHK UPDates
Theses
Experts List
User Guides
About Us
List of Researchers
> Research Associate Ka Wai Kay LI
Home
Research Outputs
Researcher Profiles
Department Profiles
Research Areas
Dr LI Ka Wai Kay
Personal Information
CUHK Research Outputs
1 of 2
Molecular landscapes of longitudinal NF2/22q and non-NF2/22q meningiomas show different life histories
(
2023
)
Combinations of Single-Gene Biomarkers Can Precisely Stratify 1,028 Adult Gliomas for Prognostication
(
2022
)
Expanding the clinical and molecular spectrum of pituitary blastoma
(
2022
)
Molecular landscape of IDH-wild-type, H3-wild-type glioblastomas of adolescents and young adults
(
2022
)
Molecular landscape of pediatric type IDH wildtype, H3 wildtype hemispheric glioblastomas
(
2022
)
Low-grade BRAF V600E mutant oligodendroglioma-like tumors of children may show EGFR and MET amplification
(
2021
)
Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas
(
2021
)
The transcriptional landscape of Shh medulloblastoma
(
2021
)
Clinical and mutational profiles of adult medulloblastoma groups
(
2020
)
IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations
(
2020
)
Incremental prognostic value and underlying biological pathways of radiomics patterns in medulloblastoma
(
2020
)
Molecular subgrouping of medulloblastoma based on few-shot learning of multitasking using conventional MR images: a retrospective multicenter study
(
2020
)
Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma
(
2020
)
Radiomic Features From Multi-Parameter MRI Combined With Clinical Parameters Predict Molecular Subgroups in Patients With Medulloblastoma
(
2020
)
Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks
(
2019
)
Whole-exome sequencing revealed mutational profiles of giant cell glioblastomas
(
2019
)
Adult IDH wild-type lower-grade gliomas should be further stratified
(
2017
)
Adult IDH wild-type lower-grade gliomas should be further stratified
(
2017
)
Intertumoral Heterogeneity within Medulloblastoma Subgroups
(
2017
)
The kinesin KIF14 is overexpressed in medulloblastoma and downregulation of KIF14 suppressed tumor proliferation and induced apoptosis
(
2017
)
Aberrantly expressed microRNA in BRAF mutated young adult GBM
(
2016
)
ABERRANTLY EXPRESSED microRNAs IN BRAF MUTATED YOUNG ADULT GBM
(
2016
)
Biomarker-based prognostic stratification of young adult glioblastoma
(
2016
)
Clinicopathological analysis of UHRF1 expression in medulloblastoma tissues and its regulation on tumor cell proliferation
(
2016
)
HG-07 Aberrantly Expressed microRNAs in BRAF Mutated Young Adult GBM
(
2016
)
Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic
(
2016
)
Pediatric oligodendroglioma patients exhibit large differences with their adult counterparts: excellent survival and rarely detected molecular markers
(
2016
)
Combination genetic signature stratifies lower-grade gliomas better than histological grade
(
2015
)
CRMP1 Inhibits Proliferation of Medulloblastoma and Is Regulated by HMGA1
(
2015
)
H3F3A, IDH1 and BRAF mutations define clinical subgroups of young adult GBM
(
2015
)
Molecular markers in 1p/19q intact oligodendroglial tumors
(
2015
)
MPTH-24. COMBINATION GENETIC SIGNATURE STRATIFIESPROGNOSIS IN LOWER-GRADE GLIOMAS BUT IDH STATUSALONE DOES NOT SUPERSEDE HISTOLOGIC GRADES
(
2015
)
TERT promoter mutations contribute to subset prognostication of lower-grade gliomas
(
2015
)
Induction of antigen-specific immune responses by dendritic cells transduced with a recombinant lentiviral vector encoding MAGE-A3 gene
(
2014
)
Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors
(
2014
)
Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors
(
2014
)
Medulloblastoma in China: Clinicopathologic Analyses of SHH, WNT, and Non-SHH/WNT Molecular Subgroups Reveal Different Therapeutic Responses to Adjuvant Chemotherapy
(
2014
)
TERT promoter mutations contribute to subset prognostication of lower grade gliomas
(
2014
)
MIR-137 Suppresses Growth and Invasion, is Downregulated in Oligodendroglial Tumors and Targets CSE1L
(
2013
)
Signaling pathway and molecular subgroups of medulloblastoma
(
2013
)
Is any functional role of Minichromosome Maintenance Proteins beyond DNA replication licensing in medulloblastoma?
(
2010
)
KIAA0495/PDAM Is Frequently Downregulated in Oligodendroglial Tumors and Its Knockdown by siRNA Induces Cisplatin Resistance in Glioma Cells
(
2010
)
miR-124 is frequently down-regulated in medulloblastoma and is a negative regulator of SLC16A1
(
2009
)
Overexpression and Biological Signficance of MCM7 in Medulloblastoma
(
2009
)
Roles of MCM7 in Development of Medulloblastoma
(
2008
)
EMP3 overexpression is associated with oligodendroglial tumors retaining chromosome arms 1p and 19q
(
2007
)
Anticancer activity of a series of platinum complexes integrating demethylcantharidin with isomers of 1,2-diaminocyclohexane
(
2006
)
Promoter hypermethylation profile of RASSF1A, FHIT, and sFRP1 in intracraniat primitive neuroectodermal tumors
(
2005
)
Reduced Expression of KIAA0495, A Candidate Tumor Suppressor at Chromosome 1p36.32, in Oligodendrogliomas
(
2005
)
Involvement of Protein Phosphatase 2A in the Mechanism of Action of Novel TCM-Platinum Anticancer Agents
(
2004
)
Share Link
Last updated on 2024-03-09 at 16:08
Share Link
Your name*
Your email*
Recipient's name*
Recipient's email*
Message
Auxilliary Information
No information will be stored or shared with any third party.
Cancel
Our policy towards the use of cookies
All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Ok to Continue
Cookie Policy